Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 331 followers

Latest posts

Last updated about 11 hours ago

Human medicines European public assessment report (EPAR): Mekinist, trametinib, Date of authorisation: 30/06/2014, Revision: 39, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Mekinist, trametinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine (adsorbed), Date of authorisation: 29/03/2009, Revision: 37, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Synflorix, pneumococcal polysaccharide conjugate vaccine...

Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 18, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of...

Product-specific bioequivalence guidance

about 12 hours ago

Product-specific bioequivalence guidance

Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (27 March 2026 - 23 April 2026)

about 12 hours ago

Start of procedure: Type II Variation - Extension of indication under evaluation...

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 41, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of...

Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 23, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of...

Human medicines European public assessment report (EPAR): Tuyory, tocilizumab, Date of authorisation: 27/04/2026, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Tuyory, tocilizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation: 26/08/2013, Revision: 40, Status: Authorised

about 14 hours ago

Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Date of authorisation...

Agenda of the CVMP meeting 19-21 May 2026

about 14 hours ago

Agenda of the CVMP meeting 19-21 May 2026

Presentation - CTIS Bitesize Talk: End of transition period and notifications including serious breaches

about 15 hours ago

Presentation - CTIS Bitesize Talk: End of transition period and notifications including...

Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation: 05/01/2024, Revision: 10, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Spexotras, trametinib, Date of authorisation...